Pien Howard H
SEC-identified person · CIK 1187152 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Idera Pharmaceuticals, INC. IDRA | Director | filed 2018–2020 |
| Juno Therapeutics, Inc. JUNO | Director | filed 2014–2018 |
| Immunogen, Inc. IMGN | Director | filed 2007–2018 |
| Sage Therapeutics, Inc. SAGE | Director | filed 2014–2016 |
| Vanda Pharmaceuticals Inc. VNDA | Director | filed 2007–2015 |
| Viropharma INC VPHM | Director | filed 2006–2014 |
| Talon Therapeutics, Inc. TLON.OB | Director | filed 2012–2013 |
| Medarex INC MEDX | Director · President and CEO | filed 2007–2009 |
| Chiron Corp CHIR | Director · Chairman & CEO | filed 2006–2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.